« Back
Home /
MRE-269

MRE-269

Manufacturer	MedChem Express
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Testicular & Prostate Cancer
Type	Inhibitors
Specific against	other
Amount	10 mg
Item no.	HY-79593-10mg
Targets	Prostaglandin Receptor
CASRN	475085-57-5
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	419.52
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cardiovascular Disease; Endocrinology
Solubility	DMSO : 50 mg/mL (ultrasonic)
Manufacturers Target	Prostaglandin Receptor
Isoform	IP
Pathway	GPCR/G Protein
Manufacturers Product type	Natural Products

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-79593-10mg-safety-datasheet.pdf